Crosstalk between Arg 1175 methylation and Tyr 1173 phosphorylation negatively modulates EGFR-mediated ERK activation

  • Nat Cell Biol. 2011 Feb;13(2):174-81. doi: 10.1038/ncb2158.
Jung-Mao Hsu  1 ,  Chun-Te Chen ,  Chao-Kai Chou ,  Hsu-Ping Kuo ,  Long-Yuan Li ,  Chun-Yi Lin ,  Hong-Jen Lee ,  Ying-Nai Wang ,  Mo Liu ,  Hsin-Wei Liao ,  Bin Shi ,  Chien-Chen Lai ,  Mark T Bedford ,  Chang-Hai Tsai ,  Mien-Chie Hung
Affiliations
  • 1. Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Abstract

Epidermal growth factor receptor (EGFR) can undergo post-translational modifications, including phosphorylation, glycosylation and ubiquitylation, leading to diverse physiological consequences and modulation of its biological activity. There is increasing evidence that methylation may parallel other post-translational modifications in the regulation of various biological processes. It is still not known, however, whether EGFR is regulated by this post-translational event. Here, we show that EGFR Arg 1175 is methylated by an arginine methyltransferase, PRMT5. Arg 1175 methylation positively modulates EGF-induced EGFR trans-autophosphorylation at Tyr 1173, which governs ERK activation. Abolishment of Arg 1175 methylation enhances EGF-stimulated ERK activation by reducing SHP1 recruitment to EGFR, resulting in augmented cell proliferation, migration and invasion of EGFR-expressing cells. Therefore, we propose a model in which the regulatory crosstalk between PRMT5-mediated Arg 1175 methylation and EGF-induced Tyr 1173 phosphorylation attenuates EGFR-mediated ERK activation.